Skip to main content

Table 1 Results of FoundationOne® companion diagnostic (F1CDx) assay

From: A first case of ductal adenocarcinoma of the prostate having characteristics of neuroendocrine phenotype with PTEN, RB1 and TP53 alterations

Biomarker findings Genomic findings
MSI Cannot be determined PTEN R233fs*10, splice site 480_492 + 2delCAGAGACAAAAAGGT
TMB 3Muts/Mb RB1 Loss
   TP53 R249G
  1. MSI, microsatellite instability; TMB, tumor mutational burden